Loading...
MORT | REET | MORT / REET | |
Gain YTD | -5.091 | -6.789 | 75% |
Net Assets | 262M | 3.39B | 8% |
Total Expense Ratio | N/A | N/A | - |
Turnover | 19.00 | 7.00 | 271% |
Yield | 12.31 | 3.26 | 378% |
Fund Existence | 13 years | 10 years | - |
MORT | REET | |
---|---|---|
RSI ODDS (%) | 2 days ago79% | 2 days ago87% |
Stochastic ODDS (%) | 2 days ago83% | 2 days ago86% |
Momentum ODDS (%) | 2 days ago74% | 2 days ago74% |
MACD ODDS (%) | 2 days ago90% | 2 days ago80% |
TrendWeek ODDS (%) | 2 days ago87% | 2 days ago84% |
TrendMonth ODDS (%) | 2 days ago82% | 2 days ago77% |
Advances ODDS (%) | 2 days ago87% | 2 days ago84% |
Declines ODDS (%) | 9 days ago84% | 8 days ago83% |
BollingerBands ODDS (%) | 2 days ago85% | 2 days ago86% |
Aroon ODDS (%) | 2 days ago80% | 2 days ago81% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JGSMX | 20.58 | 0.40 | +1.98% |
JPMorgan Small Cap Growth R6 | |||
RGACX | 66.69 | 1.25 | +1.91% |
American Funds Growth Fund of Amer R3 | |||
GSIEX | 27.64 | 0.33 | +1.21% |
Goldman Sachs International Eq ESG Instl | |||
RYOAX | 57.87 | 0.61 | +1.07% |
Rydex Biotechnology H | |||
USRAX | 30.05 | 0.29 | +0.97% |
Horizon Multi-Factor U.S. Equity Inv |
A.I.dvisor indicates that over the last year, MORT has been closely correlated with NLY. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if MORT jumps, then NLY could also see price increases.
Ticker / NAME | Correlation To MORT | 1D Price Change % | ||
---|---|---|---|---|
MORT | 100% | +1.67% | ||
NLY - MORT | 88% Closely correlated | +1.69% | ||
STWD - MORT | 88% Closely correlated | +1.13% | ||
DX - MORT | 87% Closely correlated | +3.23% | ||
BRSP - MORT | 87% Closely correlated | +1.25% | ||
RITM - MORT | 86% Closely correlated | +1.28% | ||
More |